Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
06/10/2025 17:01
Oct 6 (Reuters) - Dancann Pharma A/S DAN0.F: DANCANN PHARMA A/S HAS RESOLVED TO APPLY FOR DELISTING FROM SPOTLIGHT STOCK MARKET, SUBJECT TO APPROVAL BY THE GENERAL MEETING Source text: ID:nWkrbMD1jF Further company coverage: DAN0.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874